It is fairly accepted that in the post-developmental stage of life, GH and IGF1 have numerous beneficial actions in skeletal muscle and cardiovascular and nervous systems, but a negative effect on insulin sensitivity and cancer risk. The gene discussed is GH1; the disease is cancer.